Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Benitec Biopharma Inc.

NASDAQ: BNTC · Life Sciences · 7 alerts · CIK 1808898

Share price
$8.54Close, Nov 16
Market cap
$298M
Shares outstanding
34.88MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Benitec Biopharma Inc. filings on SEC EDGAR ↗

8:03 AM ET 8-K
Clinical Trial Data

Benitec Biopharma Clinical Trial Data

Benitec Biopharma announced positive interim Phase 1b/2a results for its gene therapy BB-301 in patients with Oculopharyngeal Muscular Dystrophy (OPMD). The data showed a 100% responder rate across both low and high dose cohorts, with the high dose group demonstrating greater relative improvements in throat emptying and swallowing capacity at the 3-month mark.

8:08 AM ET 8-K
M&A Deal

Benitec Biopharma M&A Deal with U.S. Food and Drug Administration

Benitec Biopharma provided a status and timeline update for its BB-301 program following a Type C meeting with the FDA. The company remains on track to initiate a pivotal study in mid-2027, with the final study design expected to be confirmed in Q1 2027 after the FDA reviews additional natural history data.

Counterparty
U.S. Food and Drug Administration

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.